Intensive treatment may delay microvascular complicationsBut the approach comes at the cost of increased mortality, ACCORD trial shows Check for eating disorders in female type 1 diabeticsPatterns in HbA1c, hypoglycemic episodes and menses can offer clues Statins underused in diabetics U.S. researcher calls for more integrated approach to treating hyperglycemia and dyslipidemia to lower cardiovascular risks Sensor-augmented insulin pump pays off in type 1 diabetes Technology helps patients of all ages reach HbA1c targets by monitoring blood-glucose trends Dialing up diabetes data Guide to OTC Health Management: Diabetes and lifestyle Using food and fitness to manage diabetes FDA committees split on rosiglitazone Market withdrawal is most popular option, but not a majority vote Team care model for diabetes gaining support Division of tasks among care providers makes use of specialized training to improve patients’ understanding Rosiglitazone controversy continues to smolder Ask the Experts: DPP-4 inhibitors in the management of type 2 diabetes Q. What is the recommended role of DPP-4 inhibitors, such as sitagliptin and saxagliptin, in the management of type 2 diabetes? First Previous 55 56 57 58 59 Next Last
